GULDSMED HELLE ELMGREEN A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.8% 1.0% 1.5% 1.0% 1.3%  
Credit score (0-100)  74 87 76 85 80  
Credit rating  A A A A A  
Credit limit (kDKK)  2.8 211.7 23.7 328.5 75.6  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Gross profit  3,117 3,253 3,688 3,901 3,588  
EBITDA  345 661 878 1,038 628  
EBIT  131 450 664 817 407  
Pre-tax profit (PTP)  29.3 369.2 607.1 769.8 358.0  
Net earnings  20.8 286.2 470.0 596.7 274.1  
Pre-tax profit without non-rec. items  29.3 369 607 770 358  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  1,071 886 737 517 296  
Shareholders equity total  3,222 3,508 3,868 4,351 4,426  
Interest-bearing liabilities  1,320 791 562 320 396  
Balance sheet total (assets)  6,439 6,303 8,733 8,152 6,602  

Net Debt  1,155 662 -1,586 -876 312  
 
See the entire balance sheet

Volume 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,117 3,253 3,688 3,901 3,588  
Gross profit growth  -0.4% 4.3% 13.4% 5.8% -8.0%  
Employees  7 5 6 6 6  
Employee growth %  0.0% -18.2% 11.1% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  6,439 6,303 8,733 8,152 6,602  
Balance sheet change%  -3.3% -2.1% 38.5% -6.6% -19.0%  
Added value  130.8 449.8 664.5 817.4 407.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -428 -397 -362 -441 -441  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  4.2% 13.8% 18.0% 21.0% 11.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  2.0% 7.1% 8.8% 9.7% 5.5%  
ROI %  2.9% 9.9% 14.7% 17.6% 8.5%  
ROE %  0.6% 8.5% 12.7% 14.5% 6.2%  

Solidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  50.0% 55.7% 44.3% 53.4% 67.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  334.8% 100.2% -180.6% -84.4% 49.7%  
Gearing %  41.0% 22.5% 14.5% 7.3% 9.0%  
Net interest  0 0 0 0 0  
Financing costs %  8.0% 7.6% 8.5% 11.1% 13.8%  

Liquidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  0.3 0.1 0.5 0.4 0.1  
Current Ratio  2.3 2.6 1.8 2.1 3.0  
Cash and cash equivalent  165.3 128.8 2,147.7 1,195.3 84.6  

Capital use efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  3,064.8 3,349.4 3,583.7 3,994.5 4,174.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  20 83 111 136 68  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  52 122 146 173 105  
EBIT / employee  20 83 111 136 68  
Net earnings / employee  3 53 78 99 46